SCIENCE CORPORATION IMPLANTS ITS VISION-RESTORING CHIP IN ITS FIRST STARGARDT DISEASE PATIENT

Summary from the TLDR newsletter

Science Corporation's vision-restoring chip, PRIMA, is commercially available in Europe for patients who have lost their sight to an advanced form of age-related macular degeneration, but the company believes its approach can be applied to multiple diseases. It recently implanted the chip in a patient with Stargardt disease, an inherited eye disease that gradually destroys central vision. The company's work with PRIMA is part of a broader pursuit of a novel brain-computer interface. It envisions a future where BCIs expand into a wide range of medical technology applications rather than just being used to control computers.